Academia
Researchers with Iowa-based Cellular Engineering Technologies, the John Paul II Medical Research Institute and the University of Iowa published research in late 2018 describing a safer and ethical method of creating pluripotent stem cells from cord blood and peripheral blood.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
Protein engineering extends immune cell vocabulary
A Dolomite Microfluidics’ set-up for high throughput single cell encapsulation is helping researchers at the Department of Medicine at Imperial College, London, to develop novel liposomal formulations for RNA vaccines targeting diseases such as HIV, influenza, rabies and chlamydia.
Cancer Research UK, a cancer research and awareness charity in the United Kingdom and Isle of Man, recently announced its latest Grand Challenge winners. This cancer research grant awards a series of £20 million wards to international, multidisciplinary teams that focus on unique and new approaches to cancer.
Scientists at DZNE, the Hertie Institute for Clinical Brain Research (HIH) and the University Hospital Tuebingen identified a protein in blood that can precisely track Alzheimer’s disease progression before the first symptoms appear.
People with Alzheimer’s disease who used antiepileptic drugs had a higher number of accumulated hospital days than people with Alzheimer’s disease who did not use antiepileptics, according to a new study from the University of Eastern Finland.
China government officials told the Xinhua News Agency that the researcher who became world famous for using CRISPR on human embryos “will be transferred to public security authorities,” and the individuals involved in the research will be “severely dealt with according to the law.”
Novartis and Oxford will use artificial intelligence and advanced analytics to identify early predictors of inflammatory diseases.
There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.
PRESS RELEASES